Miruvor
Sign up
The short answer

What studies of aquatic therapy / hydrotherapy found

12papers on aquatic therapy / hydrotherapy
81people in 4 studies testing aquatic therapy / hydrotherapy alone
3randomised trials, the strongest kind of study

At a glance, by condition

Long COVID: D Little or no difference

Based on the strongest evidence, the randomised trial and studies with no comparison group (very low certainty): 4 findings, all D.

3 outcomes rated · see each below

ME/CFS: D Little or no difference

Based on the strongest evidence, the randomised trial and studies with no comparison group (very low certainty): 5 of 9 findings are D.

5 outcomes rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: For long COVID, studies found little or no difference with aquatic therapy / hydrotherapy. For ME/CFS, studies found little or no difference with aquatic therapy / hydrotherapy. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 12 papers.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. C
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. Aquatic therapy / hydrotherapy · Long COVID is hereAquatic therapy / hydrotherapy · ME/CFS is hereD
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

Long COVID

Fatigue1 study · 74 people took part in aquatic therapy / hydrotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 74 people found no clear difference; a small benefit can't be ruled out.

The randomised trial86 randomised · 74 analysed · eight weeks · twice a week, 45 min per session, for eight weeks

No clear difference in fatigue.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on fatigue in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 74 people found no clear difference; a small benefit can't be ruled out
See the 1 study
  1. Effect of Water-Based vs. Land-Based Exercise Intervention (postCOVIDkids) on Exercise Capacity, Fatigue, and Quality of Life in Children with Post COVID-19 Condition: A Randomized Controlled Trial. (2023)

    People in the study
    86 randomised · 74 analysed
    Dose
    twice a week, 45 min per session, for eight weeks
    Outcome
    change in total fatigue score or individual fatigue symptoms (complaint rate) Cumulative Fatigue Symptoms Questionnaire (CFSQ)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    High
Breathlessness2 studies · 53 people took part in aquatic therapy / hydrotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 74 people found no clear difference; a small benefit can't be ruled out.

The randomised trial86 randomised · 74 analysed · 8 weeks · 8 weeks, with a frequency of 2 days per week (16 sessions in total) and the duration of each session was 45 min

No clear difference in breathlessness.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on breathlessness in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 74 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group29 randomised · 28 started · 23 analysed · before and after the multidisciplinary rehabilitation programme involving aquatic exercises · 7 sessions

No clear change in breathlessness.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on breathlessness in long COVID. Little or no difference · very low certainty D

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (28 in all)
See the 2 studies
  1. Effect of water- and land-based exercise on lung function in children with post-COVID-19 condition: secondary results from a randomised controlled trial. (2025)

    People in the study
    86 randomised · 74 analysed
    Dose
    8 weeks, with a frequency of 2 days per week (16 sessions in total) and the duration of each session was 45 min
    Outcome
    FVC % pred forced vital capacity
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Can aquatic exercises contribute to the improvement of the gait stereotype function in patients with Long COVID outcomes? (2022)

    People in the study
    29 randomised · 28 started · 23 analysed
    Dose
    7 sessions
    Outcome
    Spirometry data spirometry
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Autonomic symptoms1 study · 28 people took part in aquatic therapy / hydrotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (28 in all).

Studies with no comparison group29 randomised · 28 started · 23 analysed · before and after the multidisciplinary rehabilitation programme involving aquatic exercises · 7 sessions

No clear change in autonomic symptoms.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on autonomic symptoms in long COVID. Little or no difference · very low certainty D

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (28 in all)
See the 1 study
  1. Can aquatic exercises contribute to the improvement of the gait stereotype function in patients with Long COVID outcomes? (2022)

    People in the study
    29 randomised · 28 started · 23 analysed
    Dose
    7 sessions
    Outcome
    Cardiointervalography (CIG) values cardiointervalography
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I

ME/CFS

Symptoms

Breathlessness2 studies · 28 people took part in aquatic therapy / hydrotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 32 people found no clear difference; a small benefit can't be ruled out.

The randomised trial34 randomised · 32 started · 32 analysed · 6 months · two 20-min sessions per week, twice weekly

No clear difference in breathlessness.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on breathlessness in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 32 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group11 in the study · 5-week program · initial 20-min aquatic exercise session then two self-paced 20-min sessions per week for 4 weeks, twice-weekly aquatic sessions with 48–72 h recovery between sessions

Breathlessness improved.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on breathlessness in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (11 in all)
See the 2 studies
  1. Physical function and psychosocial outcomes after a 6-month self-paced aquatic exercise program for individuals with myalgic encephalomyelitis/chronic fatigue syndrome. (2025)

    People in the study
    34 randomised · 32 started · 32 analysed
    Dose
    two 20-min sessions per week, twice weekly
    Outcome
    PEF (L/s)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Effects of a short-term aquatic exercise intervention on symptoms and exercise capacity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a pilot study. (2018)

    People in the study
    11 in the study
    Dose
    initial 20-min aquatic exercise session then two self-paced 20-min sessions per week for 4 weeks, twice-weekly aquatic sessions with 48–72 h recovery between sessions
    Outcome
    Oxygen saturation at the post-intervention 2-min time point 6 min Walk Test
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Fatigue2 studies · 28 people took part in aquatic therapy / hydrotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 32 people found no clear difference; a small benefit can't be ruled out.

The randomised trial34 randomised · 32 started · 32 analysed · 6 months · two 20-min sessions per week, twice weekly

No clear difference in fatigue.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on fatigue in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 32 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group11 in the study · 5-week program · initial 20-min aquatic exercise session then two self-paced 20-min sessions per week for 4 weeks, twice-weekly aquatic sessions with 48–72 h recovery between sessions

Fatigue improved.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on fatigue in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (11 in all)
See the 2 studies
  1. Physical function and psychosocial outcomes after a 6-month self-paced aquatic exercise program for individuals with myalgic encephalomyelitis/chronic fatigue syndrome. (2025)

    People in the study
    34 randomised · 32 started · 32 analysed
    Dose
    two 20-min sessions per week, twice weekly
    Outcome
    Post-6MWT tiredness (VAS 0–10)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Effects of a short-term aquatic exercise intervention on symptoms and exercise capacity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a pilot study. (2018)

    People in the study
    11 in the study
    Dose
    initial 20-min aquatic exercise session then two self-paced 20-min sessions per week for 4 weeks, twice-weekly aquatic sessions with 48–72 h recovery between sessions
    Outcome
    FACIT scores Functional Assessment of Chronic Illness Therapy-Fatigue
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Pain2 studies · 28 people took part in aquatic therapy / hydrotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 32 people found no clear difference; a small benefit can't be ruled out.

The randomised trial34 randomised · 32 started · 32 analysed · 6 months · two 20-min sessions per week, twice weekly

No clear difference in pain.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on pain in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 32 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group11 in the study · 5-week program · initial 20-min aquatic exercise session then two self-paced 20-min sessions per week for 4 weeks, twice-weekly aquatic sessions with 48–72 h recovery between sessions

Pain improved.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on pain in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (11 in all)
See the 2 studies
  1. Physical function and psychosocial outcomes after a 6-month self-paced aquatic exercise program for individuals with myalgic encephalomyelitis/chronic fatigue syndrome. (2025)

    People in the study
    34 randomised · 32 started · 32 analysed
    Dose
    two 20-min sessions per week, twice weekly
    Outcome
    Post-6MWT pain (VAS 0–10)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Effects of a short-term aquatic exercise intervention on symptoms and exercise capacity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a pilot study. (2018)

    People in the study
    11 in the study
    Dose
    initial 20-min aquatic exercise session then two self-paced 20-min sessions per week for 4 weeks, twice-weekly aquatic sessions with 48–72 h recovery between sessions
    Outcome
    24-h post-test pain Visual Analogue Scale (VAS)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Autonomic symptoms1 study · 17 people took part in aquatic therapy / hydrotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 32 people found no clear difference; a small benefit can't be ruled out.

The randomised trial34 randomised · 32 started · 32 analysed · 6 months · two 20-min sessions per week, twice weekly

No clear difference in autonomic symptoms.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on autonomic symptoms in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 32 people found no clear difference; a small benefit can't be ruled out
See the 1 study
  1. Physical function and psychosocial outcomes after a 6-month self-paced aquatic exercise program for individuals with myalgic encephalomyelitis/chronic fatigue syndrome. (2025)

    People in the study
    34 randomised · 32 started · 32 analysed
    Dose
    two 20-min sessions per week, twice weekly
    Outcome
    Resting DBP (mmHg)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns

Daily life and health overall

Daily functioning2 studies · 28 people took part in aquatic therapy / hydrotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 32 people found no clear difference; a small benefit can't be ruled out.

The randomised trial34 randomised · 32 started · 32 analysed · 6 months · two 20-min sessions per week, twice weekly

No clear difference in daily functioning.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on daily functioning in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 32 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group11 in the study · 5-week program · initial 20-min aquatic exercise session then two self-paced 20-min sessions per week for 4 weeks, twice-weekly aquatic sessions with 48–72 h recovery between sessions

Daily functioning improved.

The evidence is very uncertain about the effect of Aquatic therapy / hydrotherapy on daily functioning in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (11 in all)

Combination: CBT and psychotherapy + Physical therapy / physiotherapy + Aquatic therapy / hydrotherapy

Adolescents with severe chronic fatigue syndrome can make a full recovery. (2011): A level results and sports scholarship, better (not tested).

Shown, not counted: aquatic therapy / hydrotherapy was given together with other treatments.

See the 2 studies
  1. Physical function and psychosocial outcomes after a 6-month self-paced aquatic exercise program for individuals with myalgic encephalomyelitis/chronic fatigue syndrome. (2025)

    People in the study
    34 randomised · 32 started · 32 analysed
    Dose
    two 20-min sessions per week, twice weekly
    Outcome
    6 MWT distance (m)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Effects of a short-term aquatic exercise intervention on symptoms and exercise capacity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a pilot study. (2018)

    People in the study
    11 in the study
    Dose
    initial 20-min aquatic exercise session then two self-paced 20-min sessions per week for 4 weeks, twice-weekly aquatic sessions with 48–72 h recovery between sessions
    Outcome
    6MWT distance 6-min Walk Test (6MWT)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I

Side effects

Side effects studies reported1 kind
Side effects studies reported, and how many studies reported each
Side effectStudies that reported it
Worse symptoms or a flare1 study

All papers

  1. Physical function and psychosocial outcomes after a 6-month self-paced aquatic exercise program for individuals with myalgic encephalomyelitis/chronic fatigue syndrome.2025 · randomised trial · 34 randomised · 32 started · 32 analysed
    Summary

    This randomized controlled trial asked whether a 6-month self-paced aquatic exercise program changed physical function, symptoms and psychosocial measures in ME/CFS. Thirty-four individuals were initially recruited from the Sunshine Coast region (QLD) and the Northern Rivers area (NSW); 32 were randomized to an intervention group (INT, n = 17) or a usual care/no exercise control group (CON, n = 15). Mean age was 55.0 ± 13.9 years. INT participants were offered two 20-min sessions per week of self-paced aquatic movements and stretches for 6 months. Outcomes included 6-min walk test, hand-grip strength, Sit-to-Stand, Apley’s shoulder test, Sit–Reach test, perceived exertion, fatigue (FACIT), anxiety/depression (HADS), and tiredness and pain scores. The INT group improved 6MWT distance (P < 0.001), Sit-to-Stand (P < 0.001), PEF (P = 0.028), FACIT fatigue (P = 0.005), HADS total (P = 0.047) and HADS depression (P = 0.021), and decreased resting diastolic blood pressure (P < 0.001). FACIT fatigue was lower in INT than CON post-intervention (P = 0.003). CON had greater Sit–Reach scores than INT (P = 0.034). Between-group differences were not significant for 6MWT distance (P = 0.381), Sit-to-Stand (P = 0.618), PEF (P = 0.166) or diastolic blood pressure (P = 0.603). Tiredness and pain showed no significant within- or between-group differences. Hand grip showed no changes. There were no reported adverse events or worsening of ME/CFS symptoms; two CON participants dropped out. Attendance averaged 75%.

  2. Effect of water- and land-based exercise on lung function in children with post-COVID-19 condition: secondary results from a randomised controlled trial.2025 · randomised trial · 86 randomised · 74 analysed
    Summary

    This randomised controlled trial with a multigroup pre–post-test design included children aged 10–12 years with post-COVID-19 condition recruited from primary care clinics and schools in Warsaw, Poland. Of 86 children randomised, 74 completed the intervention; analysed group sizes were AQUA n=25, LAND n=23 and CONTROL n=26. AQUA received water-based exercise and LAND land-based exercise for 8 weeks, 2 days per week (16 sessions in total), each session 45 min; CONTROL received no exercise and was told not to change its routine. Lung function was measured with Lungtest Handy, including FEV1, FVC and VC, from baseline to immediately after the 8-week intervention. The paper reports significant GROUP×REPETITION interactions for absolute FEV1 (F(2,64)=6.80; p<0.01), FEV1 % pred (F(2,64)=6.96; p<0.01), FVC (F(2,64)=4.63; p<0.05) and FVC % pred (F(2,64)=4.99; p<0.01), but for FVC % pred there were no significant differences within or between groups. FEV1/FVC interaction was not significant (F(2,64)=0.71, p>0.05). Attendance was 84% in AQUA and 77% in LAND, with no significant difference. In CONTROL all spirometric parameters decreased (largest boys' FEV1% pred 11.3%; girls' FVC % pred 12%), but post hoc tests found no significant within-group differences. No adverse events were recorded; two new cases from the control group with restrictive disorders were found.

  3. Effect of Water-Based vs. Land-Based Exercise Intervention (postCOVIDkids) on Exercise Capacity, Fatigue, and Quality of Life in Children with Post COVID-19 Condition: A Randomized Controlled Trial.2023 · randomised trial · 86 randomised · 74 analysed
    Summary

    This three-group randomized controlled trial examined water-based exercise (AQUA), land-based exercise (LAND), and a no-exercise CONTROL in children aged 10–12 years with post COVID-19 condition, recruited from primary care clinics and schools in Warsaw (Poland). Of 86 children randomized, 74 (86%) completed the intervention and attended the post-intervention assessment. AQUA and LAND sessions were conducted twice a week, 45 min per session, for eight weeks. Exercise capacity was measured with the modified Balke treadmill protocol, fatigue with the CFSQ, and health-related quality of life with the PedsQL for children and parents. Absolute VO2max increased after AQUA (p = 0.001) and LAND (p = 0.004) but not CONTROL (p = 0.999); relative VO2max increased only in AQUA (p = 0.017). The only significant post-intervention VO2max difference was between AQUA and CONTROL (p = 0.023). No significant differences were found among groups for change in total fatigue or individual fatigue symptoms. The total PedsQL score reported by parents improved only in LAND (p < 0.01), with no between-group effect in children or parents. Mean attendance was 84% in AQUA and 77% in LAND, with no significant difference; no adverse events were recorded. The authors note a heterogeneous group and a relatively small sample size.

  4. Can aquatic exercises contribute to the improvement of the gait stereotype function in patients with Long COVID outcomes?2022 · randomised trial · 29 randomised · 28 started · 23 analysed
    Summary

    This two-stage study asked whether aquatic exercises could improve upright posture and motor function in Long COVID outcomes. Stage 1 developed and evaluated the technique in 12 patients with impaired upright posture maintenance, using the “Habilect” video gait analysis system before and after exercising; indices of deviation of the body axes and body centre of mass and direction of body movement vector decreased (p<0.05). Stage 2 was an open-label, prospective, randomized, parallel-group study conducted in a Russian rehabilitation department between July 2021 and March 2022. Twenty-nine patients were included, 28 were randomized, and 23 completed. Both arms received a multidisciplinary rehabilitation programme daily, five days a week, plus 7 aquatic exercise sessions: intervention n=14 in sodium bromide chloride brine, control n=14 in tap water. Before and after, the study measured physical examination, 6-minute step test, EuroQol-5D, Borg scale, laser Doppler flowmetry, cardiointervalography and spirometry. Both groups improved exercise tolerance on the 6-minute step test: intervention 233.71 metres [150; 320] (T=8.0, p=0.047), comparison 236.7 metres [126; 380] (T=8, p=0.047). Spirometry, Borg and CIG changes were not statistically significant (p>0.05). In the intervention group, microcirculation increased to 6.36 standard units [5.54; 8.17] (T=7.0, p=0.004), and oxidative metabolism index decreased by 6.89 standard units [4.76; 6.96] (T=4.0, p=0.03). EuroQol-5D anxiety/depression improved in the comparison group (3 [3;3], T=0, p=0.043) and remained at 2 [2;2] in the intervention group (T=6.0, p=0.69). No serious adverse events were reported; reported adverse events showed no statistically significant intergroup difference.

  5. Adolescents with severe chronic fatigue syndrome can make a full recovery.2011 · combination: given with other treatments
    Summary

    This case report describes one 11-year-old boy with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) who was virtually housebound and used a wheelchair. He was referred to a specialist unit after an 18-month illness. He received a home-based assessment and treatment package over 18 months: 25 sessions lasting between 1½ and 2 h, encouraging a consistent pattern of activity and rest, then gradually increasing activity and establishing a sleep routine. A community physiotherapist encouraged stretching and strengthening exercises, and he did aqua-aerobics weekly; a home tutor helped with schoolwork. There was no comparison group. Self-report measures of fatigue and social adjustment were given before treatment, at discharge, and at 6, 12 and 36 months post treatment; school attendance was also shown over time. At discharge, after 23 sessions over 19 months, he was back at school full-time but not participating in sports. At 3-month follow-up, his parents felt he was ‘back to normal’, and gains were maintained at 6 and 12 months. At 36 months post discharge, treatment questionnaire scores showed gains maintained. By 54 months after treatment ended, his mother reported good A level results and a sports scholarship. Harms and withdrawals were not reported. The authors state no research to date has focused on the management of severely affected adolescents with CFS/ME.

  6. Effectiveness of physical, psychological, and alternative interventions for post-COVID-19 condition: a systematic review.2026 · systematic review
    Summary

    This systematic review asked whether supervised physical, psychological and alternative non-pharmacological treatments help adults with post-COVID-19 condition. It included 27 randomized trials with 1,998 participants; trials were supervised and face-to-face and compared interventions with usual care, placebo/sham or active comparators. Interventions included cardiopulmonary rehabilitation, multimodal and unimodal exercise, CBT and lifestyle programmes, neuromodulation, oxygen therapies, acupuncture and balneotherapy. Intervention durations varied. The review reported that cardiopulmonary rehabilitation and multimodal exercise consistently improved cardiorespiratory fitness and walking capacity; CBT and lifestyle adjustments significantly reduced fatigue and subjective concentration complaints. Examples recorded: in 114 participants, CBT lowered CIS-fatigue by a between-group mean difference of −8.8 points (95% CI −11.9 to −5.8); in 70 participants, active HD-tDCS plus rehabilitation lowered MFIS total fatigue by a between-group difference of −14.03 points (95% CI −20.28 to −7.78). Findings for neuromodulation, complementary and oxygen therapies were heterogeneous, often showing no benefit over placebo. For example, HBOT did not produce significantly greater improvements than sham on any primary or secondary outcome. Side effects and withdrawals were not reported in the recorded data. The authors state that the evidence does not support definitive conclusions about the effectiveness of any intervention category.

  7. Emerging Evidence on Balneotherapy and Thermal Interventions in Post-COVID-19 Syndrome: A Systematic Review.2025 · systematic review
    Summary

    This systematic review asked whether balneotherapy and thermal interventions help post-COVID-19 syndrome. The review included six eligible studies (n = 617). The included studies enrolled people with post-COVID-19 syndrome; the review did not report a single setting. Treatments included thermal therapy, health resort treatment, sulfur thermal water inhalations, a comprehensive health resort program, various hydrotherapy modalities, and combined spa-ubiquinol therapy. Treatment duration was not recorded in the extracted data. This review had no comparison group; within included studies, Crucianelli et al. compared sulfur thermal water inhalations with placebo, and Shchikota et al. compared intervention groups with controls. Costantino et al. reported 47% reduction in chronic fatigue and 48% reduction in muscle pain; Onik et al. reported a 62% reduction in mMRC dyspnea scores (p < 0.0001) and a lack of improvement in tachycardia symptoms. Ponikowska et al. reported complete symptom resolution in 30.3% of patients and enhanced physical capacity; Shchikota et al. reported improvements in symptom reduction, cardiopulmonary function, hormonal and psychological profiles, and allostatic load compared with controls. Satisfaction was 87% in Costantino et al. and 85% in Ponikowska et al. Crucianelli et al. reported no adverse events; other studies reported only mild and transient side effects. Worsening and discontinuation were not reported. The authors state the findings must be interpreted with caution and name limitations in study designs and evolving COVID-19 safety protocols.

  8. Dropouts in Exercise Rehabilitation Program in Patients With Long COVID: A Systematic Review.2025 · systematic review
    Summary

    Objective: to describe dropout rates, reasons, and factors associated with dropout during rehabilitation programs for patients with long COVID. The review included 23 studies with 1,523 patients with long COVID (mean age 53.0 ± 6.4 yrs; 51% female). Eligible programs were exercise interventions lasting at least 4 weeks for patients aged 18 or older of both sexes. The review did not compare one exercise regimen against another; it pooled dropout data and compared dropout ratios across study variables. The main outcome was dropout rate, recorded as absolute numbers and frequency, and the secondary outcome was reasons for dropout. Of 1,523 patients enrolled, 216 withdrew, constituting 14.2% of the total sample. Grouped dropout reasons were not reported (31.0%), health issues (23.1%), did not complete assessments (19.4%), loss of interest (15.7%), lack of adherence (6.9%), and adherence to other interventions (3.7%). Individual included studies listed side effects (n = 5), symptoms exacerbation (n = 1), musculoskeletal issue (n = 1), other acute health conditions (n = 2), and hospitalization (n = 1) as dropout reasons. The review reports no significant associations between dropout rate and remaining variables. The authors state that dropout rates were 14% and that health-related issues and incomplete assessments were the most common reasons.

  9. Physical Training Protocols for Improving Dyspnea and Fatigue in Long COVID: A Systematic Review with Meta-Analysis.2025 · systematic review
    Summary

    This systematic review with meta-analysis asked which physical training protocols are used by people with long COVID to alleviate dyspnea and fatigue. The search was conducted in October 2023; 25 articles were included. The review included primary experimental studies of individuals living with long COVID; its comparison was “not applicable.” Training protocols were mostly combinations of methods, most commonly respiratory muscle training with strength and aerobic training. Other protocols included concurrent training, inspiratory muscle training (IMT), concurrent training with IMT, a self-directed program following WHO recommendations, and aerobic training alone. The text does not report a single duration for these protocols. Dyspnea and fatigue were assessed with questionnaires. Of the 17 studies that assessed dyspnea, 11 showed significant improvement after physical exercise rehabilitation; of the 20 that assessed fatigue, 10 showed significant improvement after physical training. A meta-analysis of two studies found no significant effect on reducing fatigue compared with the control group (intervention participants: 37; control: 38; 95% CI: 15.42 to 8.77; I2: 89%). A study showed periods of worsening fatigue and dyspnea as a fluctuating pattern, and in some sessions an increase in fatigue and dyspnea intensity after excessive effort. Stopping and side effects were not reported. The authors state most studies had a moderate to high risk of bias and heterogeneity limited a more comprehensive meta-analysis.

  10. EFFECTIVENESS OF THERAPEUTIC INTERVENTIONS FOR CHRONIC FATIGUE SYNDROME: A NARRATIVE REVIEW2026 · review
    Summary

    This narrative review summarized treatment studies in chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis (ME). A structured search of PubMed and Google Scholar, with ResearchGate used only to retrieve full texts, was performed in June 2026 and covered publications from 2001 to 2025; of 132 identified publications, 54 were included. Treatments included CBT, exercise-based interventions, nutritional supplements (CoQ10, NADH, selenium, creatine, combination nutraceutical therapy), rituximab and rintatolimod. Five nutritional studies assessing 265 patients reported significant fatigue improvement (p < 0.001 to p = 0.038); three studies involving 192 patients reported significant sleep improvement (p = 0.008–0.018), while one study of 27 patients receiving CoQ10 + selenium found no effect on sleep (p = 0.480). Two CoQ10 studies involving 171 patients reported significant quality-of-life improvement (p = 0.001–0.048), whereas two studies involving 46 patients found no improvement (p > 0.05). In the RituxME phase III trial, clinical response was 26.0% (20/77) with rituximab vs 35.1% (26/74) with placebo (p = 0.22); adverse events occurred in 81.8% vs 64.9%. In exercise studies, deterioration in health status was observed in 27.6% (367/1331), and 2.1% discontinued treatment due to worsening health (3% GET vs 1% AM). No advantage of GET over comparator groups was found in three different studies. The authors state that included studies differed substantially in design, diagnostic criteria, interventions, follow-up duration and outcome measures, and findings were synthesized qualitatively.

  11. Interventions for Long COVID: A Narrative Review.2025 · review
    Summary

    This narrative review synthesized evidence from 97 studies (n=8260, 103 publications) on interventions for common long COVID symptoms: fatigue, neurocognitive symptoms, anxiety, depression, and sleep issues. The review included randomized and non-randomized studies and compared medications, rehabilitation, behavioral and mind-body programs, supplements, complementary treatments, and COVID-19 vaccination with placebo, usual care, no treatment, or other active comparators. For vortioxetine versus placebo, one RCT (n = 141) reported a significant reduction in depression symptoms (adjMD of −1.52; 95% CI −2.85 to −0.19) and improvement in quality of life (WHO-5, adjMD of 2.36; 95% CI 0.77 to 3.94), with mixed cognitive results. An RCT of “Fit after COVID” CBT (n=114) reported improvement in fatigue (CIS-fatigue: MD −8.8; 95% CI −11.9 to −5.8), cognitive impairment (CIS-concentration: MD −5.1; 95% CI −6.9 to −3.4), and physical function (SF-36-Physical Health: MD 7.1; 95% CI 2.9 to 11.3). Hyperbaric oxygen therapy (n=73) improved fatigue (SF-36 energy subscale, 18.2 vs 6.0, p=0.029) and sleep quality (PSQI, 8.1 vs 9.2, p=0.042) versus sham. Transcranial direct current stimulation (n=47) reduced physical fatigue (MFIS-Physical: p=0.034) but not overall fatigue (MFIS-Total: p=0.184). A COVID-19 vaccine study (n=453) found no statistically significant difference in fatigue, depression, or sleep quality. Adverse events included treatment-related reactions with vortioxetine (26.8% vs. 22.1%), non-serious adverse events with AXA1125 (RR 2.62, 95% CI 1.00 to 6.89), and similar adverse event rates with SIM01 (10% vs. 11%; p=0.63).

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime